401480 Sigma-AldrichIKK Inhibitor III, BMS-345541 - CAS 445430-58-0 - Calbiochem
IKK Inhibitor III, BMS-345541, CAS 445430-58-0, is a cell-permeable, potent, selective, and allosteric site-binding inhibitor of IKK-2 (IC₅₀ = ~ 300 nM).
More>> IKK Inhibitor III, BMS-345541, CAS 445430-58-0, is a cell-permeable, potent, selective, and allosteric site-binding inhibitor of IKK-2 (IC₅₀ = ~ 300 nM). Less<<Synonyms: 4-(2ʹ-Aminoethyl)amino-1,8-dimethylimidazo[1,2-a]quinoxaline
Recommended Products
Overview
Replacement Information |
---|
Key Spec Table
CAS # | Empirical Formula |
---|---|
445430-58-0 | C₁₄H₁₇N₅•2CF₃CO₂H |
Products
Catalogue Number | Packaging | Qty/Pack | |
---|---|---|---|
401480-1MG | Plastová ampulka | 1 mg |
Product Information | |
---|---|
CAS number | 445430-58-0 |
ATP Competitive | N |
Form | Off-white solid |
Formulation | Supplied as bis-TFA salt. |
Hill Formula | C₁₄H₁₇N₅•2CF₃CO₂H |
Chemical formula | C₁₄H₁₇N₅•2CF₃CO₂H |
Hygroscopic | Hygroscopic |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalogue Number | GTIN |
401480-1MG | 04055977211955 |
Documentation
IKK Inhibitor III, BMS-345541 - CAS 445430-58-0 - Calbiochem MSDS
Title |
---|
IKK Inhibitor III, BMS-345541 - CAS 445430-58-0 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
401480 |
References
Reference overview |
---|
Townsend, R.M., et al. 2004. Transplantation 77, 1090. MacMaster, J.F., et al. 2003. Inflamm. Res. 52, 508. McIntyre, K.W., et al. 2003. Arthritis Rheum. 48, 2652. Burke, J. R., et al. 2003. J. Biol. Chem. 278, 1450. |